BIO-key stock to resume Nasdaq trading on July 8, 2026

The company said a Nasdaq Hearings Panel found it back in compliance with minimum bid price and SEC filing requirements after a June 16 hearing.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.